Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Enzyme Inhibitors. Found 38 abstracts

no pagination
Buuh ZY, Lyu Z, Wang RE. Interrogating the Roles of Post-Translational Modifications of Non-Histone Proteins. Journal of medicinal chemistry. 2018 Apr 26;61(8):3239-52.
Chu J, Li JG, Giannopoulos PF, Blass BE, Childers W, Abou-Gharbia M, Pratico D. Pharmacologic blockade of 12/15-lipoxygenase ameliorates memory deficits, Abeta and tau neuropathology in the triple-transgenic mice. Mol Psychiatry. 2015 Nov;20(11):1329-38.
McCullough SD, Duncan KE, Swanton SM, Dailey LA, Diaz-Sanchez D, Devlin RB. Ozone induces a proinflammatory response in primary human bronchial epithelial cells through mitogen-activated protein kinase activation without nuclear factor-kappaB activation. Am J Respir Cell Mol Biol. 2014 Sep;51(3):426-35.
Teijaro CN, Munagala S, Zhao S, Sirasani G, Kokkonda P, Malofeeva EV, Hopper-Borge E, Andrade RB. Synthesis and biological evaluation of pentacyclic strychnos alkaloids as selective modulators of the ABCC10 (MRP7) efflux pump. Journal of medicinal chemistry. 2014 Dec 26;57(24):10383-90.   PMCID: PMC4281106
Arias-Romero LE, Villamar-Cruz O, Pacheco A, Kosoff R, Huang M, Muthuswamy SK, Chernoff J. A Rac-Pak signaling pathway is essential for ErbB2-mediated transformation of human breast epithelial cancer cells. Oncogene. 2010 Oct 28;29(43):5839-49.   PMCID: PMC2965784
Ramirez UD, Myachina F, Stith L, Jaffe EK. Docking to large allosteric binding sites on protein surfaces. Advances in experimental medicine and biology. 2010 Jan;680:481-8.   PMCID: PMC2946403
Singh LR, Gupta S, Honig NH, Kraus JP, Kruger WD. Activation of mutant enzyme function in vivo by proteasome inhibitors and treatments that induce Hsp70. PLoS Genet. 2010 Jan;6(1):e1000807.   PMCID: PMC2795852
Chang J, Nie X, Chang HE, Han Z, Taylor J. Transcription of hepatitis delta virus RNA by RNA polymerase II. J Virol. 2008 Feb;82(3):1118-27.   PMCID: PMC2224410
Katz RA, Jack-Scott E, Narezkina A, Palagin I, Boimel P, Kulkosky J, Nicolas E, Greger JG, Skalka AM. High Frequency Epigenetic Repression and Silencing of Retroviruses can be Antagonized by HDAC Inhibitors and Transcriptional Activators, but Uniform Reactivation in Cell Clones is Restricted by Additional Mechanisms. J Virol. 2007 Jan 03;81(6):2592-604.
Pugacheva EN, Jablonski SA, Hartman TR, Henske EP, Golemis EA. HEF1-dependent Aurora A activation induces disassembly of the primary cilium.[see comment]. Cell. 2007 Jun 29;129(7):1351-63.
Altomare DA, Wang HQ, Skele KL, De Rienzo A, Klein-Szanto AJ, Godwin AK, Testa JR. AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth. Oncogene. 2004 Jul 29;23(34):5853-7.
Langer CJ. Irinotecan in advanced lung cancer: focus on North American trials. Oncology (Huntington). 2004 Jun;18(7 Suppl 4):17-28.
Lu ZJ, Markham GD. Catalytic properties of the archaeal S-adenosylmethionine decarboxylase from Methanococcus jannaschii. The Journal of biological chemistry. 2004 Jan 02;279(1):265-73.
Eisenberg BL. Imatinib mesylate: a molecularly targeted therapy for gastrointestinal stromal tumors. Oncology (Huntingt). 2003 Nov;17(11):1615-20; discussion 1620, 1623, 1626 passim.
Haas NB, Smith M, Lewis N, Littman L, Yeslow G, Joshi ID, Murgo A, Bradley J, Gordon R, Wang H, Rogatko A, Hudes GR. Weekly bryostatin-1 in metastatic renal cell carcinoma: a phase II study. Clin Cancer Res. 2003 Jan;9(1):109-14.
He J, Xu J, Xu XX, Hall RA. Cell cycle-dependent phosphorylation of Disabled-2 by cdc2. Oncogene. 2003 Jul 17;22(29):4524-30.
Meyers MO, Watson JC. Angiogenesis and hepatic colorectal metastases. Surg Oncol Clin N Am. 2003 Jan;12(1):151-63.
Winer EP, Hudis C, Burstein HJ, Bryant J, Chlebowski RT, Ingle JN, Edge SB, Mamounas EP, Gelber R, Gralow J, Goldstein LJ, Pritchard KI, Braun S, Cobleigh MA, Langer AS, Perotti J, Powles TJ, Whelan TJ, Browman GP. American Society of Clinical Oncology technology assessment working group update: use of aromatase inhibitors in the adjuvant setting. J Clin Oncol. 2003 Jul;21(13):2597-9.
Zhang L, Yang N, Katsaros D, Huang W, Park JW, Fracchioli S, Vezzani C, Rigault de la Longrais IA, Yao W, Rubin SC, Coukos G. The oncogene phosphatidylinositol 3'-kinase catalytic subunit alpha promotes angiogenesis via vascular endothelial growth factor in ovarian carcinoma. Cancer Res. 2003 Jul 15;63(14):4225-31.
Carroll PR, Kantoff PW, Balk SP, Brown MA, D'Amico A V, George DJ, Grossfeld GD, Johnson CS, Kelly WK, Klotz L, Lee WR, Lubeck DP, McLeod DG, Oh WK, Pollack A, Sartor O, Smith MR, Hart C. Overview consensus statement. Newer approaches to androgen deprivation therapy in prostate cancer. Urology. 2002 Sep;60(3 Suppl 1):1-6.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Enzyme Inhibitors

Enzyme Inhibitors pharmacology metabolism Human drug effects antagonists & inhibitors drug therapy pathology genetics therapeutic use Non-US Gov't Support Female Phosphorylation physiology Signal Transduction US Gov't Support-PHS Cell Line ai [Antagonists & Inhibitors] 0 (Enzyme Inhibitors) enzymology Proteins inhibitors Antineoplastic Agents Enzyme Activation Cultured Cells Mice chemistry dt [Drug Therapy] de [Drug Effects] antagonists & blood supply Inbred C57BL Mice biosynthesis Ovarian Neoplasms 1-Phosphatidylinositol 3-Kinase Adjuvant Chemotherapy Protein-Serine-Threonine Kinases Hela Cells Quality of Life Morpholines administration & dosage Enzymologic Gene Expression Regulation Male Cell Proliferation Pathologic Neovascularization Tumor Cell Line Cell Division Apoptosis Cisplatin Mutation Histone Deacetylases me [Metabolism] EC 2-7-1-37 (Protein-Serine-Threonine Kinases) Chromones pd [Pharmacology] Phytogenic Antineoplastic Agents Molecular Models Breast Neoplasms Mitosis 15663-27-1 (Cisplatin) Reporter Genes 103882-84-4 (gemcitabine) tu [Therapeutic Renal Cell Carcinoma Inflammation Protein Kinases EC 2-7-1 (aurora kinase) Intercellular Signaling Peptides and Proteins Pyrimidines Colorectal Neoplasms Xenograft Model Antitumor Assays Proto-Oncogene Proteins c-akt Acetylation Phytogenic) 0 (Antineoplastic Agents Protein p34cdc2 Phorbol Esters Pyrazines kinase Alkaloids SCID Mice Saccharomyces cerevisiae Air Pollutants Proto-Oncogene Proteins Porphobilinogen Synthase Hepatitis delta Antigens Trans-Activators antagonists & Lung Neoplasms Interleukin-6 Clone Cells Methylation Signal Transducing Adaptor Proteins Small Cell Carcinoma Strychnos Angiogenesis Inhibitors Phosphoprotein Phosphatase 0 (Taxoids) human) 0 (NEDD9 protein Okadaic Acid Enzyme Stability Adult Protein Kinase C Vascular Endothelial Growth Factor A Western Blotting 33419-42-0 (Etoposide) Middle Age Citrullination MAP Kinase Signaling System blood Disease Progression Camptothecin Fear p38 Mitogen-Activated Protein Kinases surgery Drug Delivery Systems 80 and over Aged Brain Fibroblasts Hepatitis Delta Virus aa [Analogs & Derivatives] Hydroxamic Acids NF-kappa B Peptidylprolyl Isomerase EC 2-7-1-137 (1-Phosphatidylinositol 3-Kinase) 0 (Chromones) Ozone Arachidonate 12-Lipoxygenase Catalytic Domain Aromatase Ubiquitination Non-Small-Cell Lung Carcinoma Immunohistochemistry Piperazines Hormone Replacement Therapy Kinetics C-Reactive Protein Taxoids Liver Neoplasms Prostatectomy Protein-Tyrosine Kinase Genetic Vectors 951-77-9 (Deoxycytidine) Prostatic Neoplasms Growth Substances RNA Polymerase II Calcineurin Paclitaxel therapy Liver Multidrug Resistance-Associated Proteins
Last updated on Friday, August 14, 2020